The lipid-binding fragment of ApoE4 works synergistically with the receptor-binding region, resulting in mitochondrial dysfunction and neurotoxicity, which can contribute to the onset of AD (Kloske and Wilcock, 2020). Here, APOE is linked to Alzheimer disease.